Chemistry discovery points to next generation inhibitors of PARP-1, a critical target in ovarian, breast and prostate cancers.
OHSU Knight Cancer Institute selected to join prestigious national consortium, receive $9.2 million
Research confirms unique danger of postpartum breast cancers
Protein study could one day advance Parkinson's, breast cancer care
OHSU Knight Cancer Institute offers the latest treatments, technologies, hundreds of research studies and clinical trials
PDF) Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
Protein study could one day advance Parkinson's, breast cancer care
A surgeon-scientist blazes a new path to immune-based cancer treatment
Portland doctors 'first in world' to apply new cancer therapy, resulting in tumor reduction : r/Futurology
Joe Rojas's Instagram, Twitter & Facebook on IDCrawl
Stories OHSU News
Focus: Cancer researchers question antitrust arguments against Illumina-Grail deal
New version of HIV vaccine could soon be ready for clinical trials
